# Lars Viktrup

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-viktrup/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,571 |
| Field | Urinary Bladder and Prostate Research |
| h-index | 45 |
| i10-index | 100 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5090431664 |
| ORCID iD | 0000-0002-8739-0544 |
| Works | 202 |

## Researcher papers

- [The symptom of stress incontinence caused by pregnancy or delivery in primiparas.](https://scholariq.org/papers/the-symptom-of-stress-incontinence-caused-by-pregnancy-or-delivery-in-primiparas/)
- [Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial](https://scholariq.org/papers/monotherapy-with-tadalafil-or-tamsulosin-similarly-improved-lower-urinary-tract/)
- [Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study](https://scholariq.org/papers/tadalafil-administered-once-daily-for-lower-urinary-tract-symptoms-secondary-to/)
- [<p>Nerve Growth Factor Signaling and Its Contribution to Pain</p>](https://scholariq.org/papers/and-lt-p-and-gt-nerve-growth-factor-signaling-and-its-contribution-to-pain-and/)
- [Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action](https://scholariq.org/papers/tadalafil-for-the-treatment-of-lower-urinary-tract-symptoms-secondary-to-benign/)
- [Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee](https://scholariq.org/papers/effect-of-tanezumab-on-joint-pain-physical-function-and-patient-global/)
- [The risk of stress incontinence 5 years after first delivery](https://scholariq.org/papers/the-risk-of-stress-incontinence-5-years-after-first-delivery/)
- [Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial](https://scholariq.org/papers/efficacy-and-safety-of-tadalafil-once-daily-in-the-treatment-of-men-with-lower/)
- [Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period](https://scholariq.org/papers/subcutaneous-tanezumab-for-osteoarthritis-of-the-hip-or-knee-efficacy-and-safety/)
- [The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia](https://scholariq.org/papers/the-mechanism-of-action-of-phosphodiesterase-type-5-inhibitors-in-the-treatment/)
- [Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States](https://scholariq.org/papers/health-care-resource-utilization-and-direct-costs-incurred-over-24-months-after/)

## Researcher topics

- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Sexual function and dysfunction studies](https://scholariq.org/topics/sexual-function-and-dysfunction-studies/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)
- [Hormonal and reproductive studies](https://scholariq.org/topics/hormonal-and-reproductive-studies/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.